Elacridar

CAS: 143664-11-3

Ref. 3D-FE22653

Produktinformation

• Name: Elacridar
• Synonyme: N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamideGF 120918GG 918, 4-acridinecarboxamide, N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-, Gf 120918, Gf 129018, Gg 918, Gw 0918, N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide, N-{4-[2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]phenyl}-5-methoxy-9-oxo-9,10-dihydroacridine-4-carboxamide
• CAS: 143664-11-3

Beschreibung

Inhibitor of ABC transporters; oral bioenhancer for anti-cancer therapy

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 563.64 g/mol
• Formel: C₃₄H₃₃N₃O₅
• Reinheit: Min. 98 Area-%
• Farbe/Form: Yellow Powder
• InChl: InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)
• InChI Key: InChIKey=OSFCMRGOZNQUSW-UHFFFAOYSA-N
• SMILES: COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2